Gleason Group Inc. Lowers Position in UnitedHealth Group Incorporated (NYSE:UNH)

Gleason Group Inc. cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 43.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 90 shares of the healthcare conglomerate’s stock after selling 69 shares during the quarter. Gleason Group Inc.’s holdings in UnitedHealth Group were worth $45,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new stake in UnitedHealth Group in the third quarter valued at $27,000. Global Wealth Strategies & Associates boosted its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC acquired a new position in UnitedHealth Group in the third quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the third quarter valued at about $37,000. Finally, Quarry LP lifted its position in shares of UnitedHealth Group by 132.1% during the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on UNH. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. KeyCorp assumed coverage on UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Barclays lifted their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research note on Wednesday, November 27th. Finally, Truist Financial dropped their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Price Performance

UNH opened at $541.28 on Tuesday. The stock has a market cap of $498.13 billion, a price-to-earnings ratio of 35.26, a PEG ratio of 1.53 and a beta of 0.62. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a fifty day moving average price of $554.92 and a 200 day moving average price of $562.88.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period in the previous year, the firm posted $6.56 earnings per share. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.